Sernova Biotherapeutics, Inc. (SVA.TO)
0.11
0.00 (0.00%)
CAD |
TSX |
Oct 23, 16:00
Sernova Biotherapeutics Net Income (Quarterly) : -2.529M for July 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -2.529M |
| April 30, 2026 | -3.228M |
| January 31, 2026 | -2.334M |
| October 31, 2025 | -2.197M |
| July 31, 2025 | -4.074M |
| April 30, 2025 | -3.777M |
| January 31, 2025 | -5.695M |
| October 31, 2024 | -4.968M |
| July 31, 2024 | -7.537M |
| April 30, 2024 | -9.944M |
| January 31, 2024 | -9.743M |
| October 31, 2023 | -11.70M |
| July 31, 2023 | -9.932M |
| April 30, 2023 | -9.347M |
| January 31, 2023 | -8.015M |
| October 31, 2022 | -8.210M |
| July 31, 2022 | -5.832M |
| April 30, 2022 | -4.920M |
| January 31, 2022 | -5.459M |
| October 31, 2021 | -2.175M |
| July 31, 2021 | -1.631M |
| April 30, 2021 | -1.667M |
| January 31, 2021 | -1.492M |
| October 31, 2020 | -1.030M |
| July 31, 2020 | -1.196M |
| Date | Value |
|---|---|
| April 30, 2020 | -1.733M |
| January 31, 2020 | -1.362M |
| October 31, 2019 | -1.759M |
| July 31, 2019 | -0.8748M |
| April 30, 2019 | -0.6134M |
| January 31, 2019 | -0.7238M |
| October 31, 2018 | -0.8344M |
| July 31, 2018 | -1.112M |
| April 30, 2018 | -0.9864M |
| January 31, 2018 | -0.7664M |
| October 31, 2017 | -0.9777M |
| July 31, 2017 | -0.7058M |
| April 30, 2017 | -0.6384M |
| January 31, 2017 | -0.3175M |
| October 31, 2016 | -0.1663M |
| July 31, 2016 | -0.9649M |
| April 30, 2016 | -0.6919M |
| January 31, 2016 | -0.6764M |
| October 31, 2015 | -0.8861M |
| July 31, 2015 | -0.6669M |
| April 30, 2015 | -0.6762M |
| January 31, 2015 | -0.6303M |
| October 31, 2014 | -0.6782M |
| July 31, 2014 | -0.7458M |
| April 30, 2014 | -0.7479M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Microbix Biosystems, Inc. | -0.8068M |
| Helix BioPharma Corp. | -0.671M |
| Hemostemix, Inc. | -0.6324M |
| Medicenna Therapeutics Corp. | -5.082M |
| Spectral Medical, Inc. | 0.331M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.529M |
| EPS Diluted (Quarterly) | -0.0067 |
| Enterprise Value | 56.09M |
| Earnings Yield | -26.73% |
| Normalized Earnings Yield | -26.73 |